See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

Allakos Raises A New $10M

Allakos, a two-year-old, San Francisco-based biotech company developing antibody-based therapeutics to treat various allergies and diseases, has raised $10 million in fresh funding from current investors. The round brings the company’s total funding to $44.5 million, shows Crunchbase.


More from